Status:
RECRUITING
Prevention of Incontinence-associated Dermatitis
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Incontinence-associated Dermatitis
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Incontinence-associated dermatitis (IAD) is an inflammation of the skin caused by prolonged direct contact of the skin with urine and/or stool. Elderly and care-dependent people are often affected by ...
Detailed Description
Incontinence-associated dermatitis (IAD) is an inflammation of the skin caused by prolonged and direct contact of the skin with urine and/or stool. It may occur in all age groups but elderly and care-...
Eligibility Criteria
Inclusion
- Geriatric patients or residents being incontinent of urine and stool
- Expected minimum length of stay of 14 days at the care facility
- Intact skin with no clinical signs of IAD OR
- intact skin with early clinical signs of IAD (IAD category 1A)
- Written informed consent
Exclusion
- Residents/patients at the end of life
- Residents/Patients with IAD category 1B, 2A, 2B and/or signs of clinical infection in the IAD area
- Any skin condition or wounds (at investigational areas of the skin) requiring additional treatment (e. g. pressure ulcers, intertrigo, infection)
- Known hypersensitivity or allergy to silicones and/or topical leave-on products
- Topical treatments in the IAD area.
Key Trial Info
Start Date :
August 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT05403762
Start Date
August 19 2022
End Date
May 31 2025
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité Universitätsmedizin Berlin
Berlin, Germany, 10117